Mori, Shahram, MD, PhD

placeholder image

visualizations

Publications in VIVO

Co-author Network

Mori, Shahram, MD, PhD
Close

research areas

Most Recent Publications

2022

Evaluation of different pharmacokinetically guided IV busulfan exposure ranges on adult patient outcomes after hematopoietic stem cell transplantation. ANNALS OF HEMATOLOGY.
Full Text via DOI: 10.1007/s00277-022-05042-z PMID: 36462061
2022

Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience. INTERNATIONAL JOURNAL OF HEMATOLOGY.
Full Text via DOI: 10.1007/s12185-022-03493-8 PMID: 36378406
2020

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. HAEMATOLOGICA. 105:1329-1338.
Full Text via DOI: 10.3324/haematol.2019.220756 PMID: 31558669
2020

Role of Post-Allogeneic Hematopoietic Stem Cell Transplantation Low-Dose Azacitidine for Prevention of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Analysis. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S126-S127.
2020

Ruxolitinib Is a Safe and Effective Therapeutic Option for Management of Chronic Gvhd - a Single Center Experience. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S193-S194.
2019

Leukemic Non-nodal Mantle Cell Lymphoma: Diagnosis and Treatment. CURRENT TREATMENT OPTIONS IN ONCOLOGY.
Full Text via DOI: 10.1007/s11864-019-0684-8 PMID: 31776787
2019

Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 25:1320-1324.
Full Text via DOI: 10.1016/j.bbmt.2019.01.027 PMID: 30710685
2019

Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome. BONE MARROW TRANSPLANTATION. 924-927.
Full Text via DOI: 10.1038/s41409-018-0407-y PMID: 30563982
2019

Higher Risks of Toxicity and Incomplete Recovery in 13-to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 25:955-964.
Full Text via DOI: 10.1016/j.bbmt.2018.12.765 PMID: 30605731
2019

Prognostic Significance of the Dynamic Change of Programmed Death-ligand 1 Expression in Patients with Multiple Myeloma. CUREUS. 11.
Full Text via DOI: 10.7759/cureus.4401 PMID: 31245191
2019

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 25:699-711.
Full Text via DOI: 10.1016/j.bbmt.2018.11.004 PMID: 30423480
2019

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. HAEMATOLOGICA. 104:844-854.
Full Text via DOI: 10.3324/haematol.2018.200121 PMID: 30381298
2019

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia. BLOOD ADVANCES. 3:670-680.
Full Text via DOI: 10.1182/bloodadvances.2018027003 PMID: 30808685
2019

Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma With P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 19:E93-E97.
Full Text via DOI: 10.1016/j.clml.2018.11.007 PMID: 30559058
2018

Addition of Cladribine: Improving Standard of Care in Newly Diagnosed Acute Myeloid Leukemia. BLOOD.
Full Text via DOI: 10.1182/blood-2018-99-120285
2018

Clinical Utility of Multiple-Gene Mutation Testing By Next-Generation Sequencing in Acute Myeloid Leukemia in Community Hospital Setting. BLOOD.
Full Text via DOI: 10.1182/blood-2018-99-119427
2018

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis. BRITISH JOURNAL OF HAEMATOLOGY. 916-920.
Full Text via DOI: 10.1111/bjh.14879 PMID: 28771676
2018

Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation: Case report and review of the literature. TRANSPLANT INFECTIOUS DISEASE.
Full Text via DOI: 10.1111/tid.12879 PMID: 29512846
2018

Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma with P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S253-S254.
2018

Eltrombopag Treatment for Primary and Secondary Thrombocytopenia Post Allogeneic and Autologous Stem Cell Transplantation is Effective and Safe. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S343-S344.
2018

Post-Transplant Low-Dose Azacitidine Can Improve Overall Survival in AML/MDS Patients and is Associated with Decrease Risks of Severe Acute and Chronic Gvhd. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S327-S327.
2018

Residual Leukemia in the Bone Marrow and/or Peripheral Blood on Day 7 of Blinatumomab Therapy Predicts Response in B-Cell Acute Lymphoblastic Leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S237-S237.
2018

Use of Nitazoxanide, an Anti-Parasitic Drug, for Management of Norovirus Ileo-Colitis in an Allogeneic Stem Cell Transplant Patient. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S394-S395.
2017

Nivolumab is Effective in Relapsed Refractory Hodgkins Lymphoma Patient Following Mismatched Allogeneic Stem Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S263-S264.
2017

Sternal Soft Tissue Mass as Initial Presentation in a Case of Acute Promyelocytic Leukemia (APL). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S208-S208.
2017

Transverse Myelitis As a Manifestation of Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S310-S310.
2016

Acute Promyelocytic Leukemia with FLT3/ITD and RUNX1 Mutation Presenting As Extramedullary Soft Tissue Mass. BLOOD.
2016

Low Dose Steroids Can Improve High Grade Febrile Episodes Associated with Blinatumomab Therapy and Limit Treatment Interruptions without Affecting Anti Leukemic Effects. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S195-S195.
2016

Steroid Refractory Acute Liver GVHD in a Hodgkin's Patient after Allogeneic Stem Transplant Cell Transplantation Following Treatment with Anti PD-1 Antibody, Nivolumab, for Relapsed Disease. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S392-S393.
2016

Thymoglobulin after Matched Unrelated Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS Results in Improved Outcomes Comparable to Matched Related HCT. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S329-S330.
2015

Low Dose Steroids Can Alleviate Blinatumomab-Associated Toxicities without Negatively Impacting Treatment Efficacy. BLOOD.
2015

Thymoglobulin Does Not Impact Relapse or Survival after Matched Unrelated Transplantation for AML/MDS Compared to Matched Related Donor Transplantation without Thymoglobulin Use. BLOOD.

Full Name

Shahram Mori, MD